Sanofi-GlaxoSmithKline Covid Vaccine Shows Promise, Firm Says - The New York Times
Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine | GSK
The Race is On as Sanofi-GSK Booster Bests Pfizer-BioNTech | BioSpace
Sanofi | World Economic Forum
GSK and Sanofi seek regulatory boost for joint Covid vaccine
Positive booster data for Sanofi/GSK COVID-19 vaccine
COVID: AIFA OKs Sanofi booster vaccine - English - ANSA.it
Sanofi says next-gen COVID booster shot has potential against main variants | Reuters
REVAXIS® Diphtheria, Tetanus & Poliomyelitis (inactivated) Vaccine (absorbed, reduced antigen(s) content) - Sanofi Campus
News - The Committee for Medicinal Products for Human Use at the EMA Recommends Authorisation of the Protein-Based COVID-19 Booster Vaccine VidPrevtyn Beta from Sanofi Pasteur - Paul-Ehrlich-Institut
Sanofi booster 'more promising' than mRNA – EURACTIV.com
Sanofi and GSK report 'positive' results from Covid booster
Magrini (Aifa), ok al vaccino booster Sanofi - Sanità - Ansa.it
Covid-19, autorizzato il vaccino booster adiuvato Sanofi-GSK
Sanofi-GSK's Covid-19 booster offers immune response against variants
Most vulnerable to be offered spring COVID-19 booster - GOV.UK
GlaxoSmithKline and Sanofi report strong results in trials of Covid vaccine | GlaxoSmithKline | The Guardian
The immunogenicity and safety of the adjuvanted recombinant protein vaccine Sanofi/GSK-D614 or -B.1.351 administered as a heterologous booster dose
Sanofi, GSK post next-gen COVID data to unlock booster market
Sanofi, GSK push COVID-19 vaccine data into 2022. Will strong booster data hold their place in line? | Fierce Biotech
Sanofi and GSK's COVID-19 booster vaccine approved by the European Commission
Vaccini, Sanofi-Gsk: «Il nostro booster funziona contro la variante Omicron» - Open
